The U.S. govt pays drugmaker Pfizer $5.29 billion for 10 million remedy classes of its attainable COVID-19 remedy if regulators authorize it.
The U.S. govt pays drugmaker Pfizer $5.29 billion for 10 million remedy classes of its attainable COVID-19 remedy if regulators authorize it.